Cargando…
Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading
BACKGROUND: Mitotic count in breast cancer is an important prognostic marker. Unfortunately, substantial inter‐ and intraobserver variation exists when pathologists manually count mitotic figures. To alleviate this problem, we developed a new technique incorporating both haematoxylin and eosin (H&am...
Autores principales: | Ibrahim, Asmaa, Toss, Michael S., Makhlouf, Shorouk, Miligy, Islam M., Minhas, Fayyaz, Rakha, Emad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100421/ https://www.ncbi.nlm.nih.gov/pubmed/36349500 http://dx.doi.org/10.1111/his.14837 |
Ejemplares similares
-
Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count?
por: Erhan, Selma Sengiz, et al.
Publicado: (2022) -
Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas
por: Zhu, Ping, et al.
Publicado: (2016) -
The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
por: Saffar, Hana, et al.
Publicado: (2021) -
Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides
por: Beuque, Manon, et al.
Publicado: (2023) -
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
por: Shin, Yooju, et al.
Publicado: (2015)